Richard John Porter

Summary

Affiliation: Christchurch School of Medicine and Health Sciences
Country: New Zealand

Publications

  1. ncbi request reprint Inadequate availability of pharmacological treatment for affective disorders in New Zealand
    Richard J Porter
    Department of Psychological Medicine, Christchurch School of Medicine
    N Z Med J 115:78-81. 2002
  2. doi request reprint Early effects of electroconvulsive therapy on cognitive function
    Richard Porter
    Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
    J ECT 24:35-9. 2008
  3. doi request reprint Monitoring of cognitive effects during a course of electroconvulsive therapy: recommendations for clinical practice
    Richard John Porter
    Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
    J ECT 24:25-34. 2008
  4. ncbi request reprint Neuropsychological impairment in major depression: its nature, origin and clinical significance
    Richard J Porter
    Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, PO Box 4345, Christchurch, New Zealand
    Aust N Z J Psychiatry 41:115-28. 2007
  5. ncbi request reprint Effects of rapid tryptophan depletion on salivary cortisol in older people recovered from depression, and the healthy elderly
    Richard J Porter
    Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, University of Otago, New Zealand, and Institute for Ageing and Health, Newcastle General Hospital, Newcastle upon Tyne, UK
    J Psychopharmacol 21:71-5. 2007
  6. ncbi request reprint Effects of acute tryptophan depletion on mood and cognitive functioning in older recovered depressed subjects
    Richard J Porter
    Dept of Psychological Medicine, P O Box 4345, Christchurch, New Zealand
    Am J Geriatr Psychiatry 13:607-15. 2005
  7. ncbi request reprint Tryptophan and tyrosine availability and response to antidepressant treatment in major depression
    Richard J Porter
    Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, P O Box 4345, Christchurch, New Zealand
    J Affect Disord 86:129-34. 2005
  8. ncbi request reprint Corticosteroid-serotonin interactions in depression: a review of the human evidence
    Richard J Porter
    Department of Psychological Medicine, Christchurch School of Medicine, Christchurch, New Zealand
    Psychopharmacology (Berl) 173:1-17. 2004
  9. ncbi request reprint Randomized controlled trials in psychiatry. Part 1: methodology and critical evaluation
    Richard Porter
    Department of Psychological Medicine, Christchurch School of Medicine, PO Box 4345, Christchurch 8001, New Zealand
    Aust N Z J Psychiatry 37:257-64. 2003
  10. ncbi request reprint Baseline prolactin and L-tryptophan availability predict response to antidepressant treatment in major depression
    Richard J Porter
    Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, P O Box 4345, Christchurch, New Zealand
    Psychopharmacology (Berl) 165:216-21. 2003

Detail Information

Publications12

  1. ncbi request reprint Inadequate availability of pharmacological treatment for affective disorders in New Zealand
    Richard J Porter
    Department of Psychological Medicine, Christchurch School of Medicine
    N Z Med J 115:78-81. 2002
    ..The current system is failing to provide appropriate or adequate treatment for people suffering from affective disorders and should be urgently reviewed...
  2. doi request reprint Early effects of electroconvulsive therapy on cognitive function
    Richard Porter
    Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
    J ECT 24:35-9. 2008
    ..We aimed to investigate the practicality of early formal cognitive screening in routine clinical practice of ECT...
  3. doi request reprint Monitoring of cognitive effects during a course of electroconvulsive therapy: recommendations for clinical practice
    Richard John Porter
    Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
    J ECT 24:25-34. 2008
    ..From this, we suggest a battery and testing schedule which may be both practical and useful in early detection of the cognitive effects of ECT...
  4. ncbi request reprint Neuropsychological impairment in major depression: its nature, origin and clinical significance
    Richard J Porter
    Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, PO Box 4345, Christchurch, New Zealand
    Aust N Z J Psychiatry 41:115-28. 2007
    ..Classification based on neuropsychological profile may, in fact, be useful. Further research should examine further the clinical importance of patterns of neuropsychological impairment...
  5. ncbi request reprint Effects of rapid tryptophan depletion on salivary cortisol in older people recovered from depression, and the healthy elderly
    Richard J Porter
    Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, University of Otago, New Zealand, and Institute for Ageing and Health, Newcastle General Hospital, Newcastle upon Tyne, UK
    J Psychopharmacol 21:71-5. 2007
    ..However, they demonstrated reduced reactivity of the HPA axis compared to healthy subjects...
  6. ncbi request reprint Effects of acute tryptophan depletion on mood and cognitive functioning in older recovered depressed subjects
    Richard J Porter
    Dept of Psychological Medicine, P O Box 4345, Christchurch, New Zealand
    Am J Geriatr Psychiatry 13:607-15. 2005
    ..These risk factors are frequent in older recovered depressed people. The authors investigated the effects of ATD on mood and cognitive functioning in this group...
  7. ncbi request reprint Tryptophan and tyrosine availability and response to antidepressant treatment in major depression
    Richard J Porter
    Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, P O Box 4345, Christchurch, New Zealand
    J Affect Disord 86:129-34. 2005
    ....
  8. ncbi request reprint Corticosteroid-serotonin interactions in depression: a review of the human evidence
    Richard J Porter
    Department of Psychological Medicine, Christchurch School of Medicine, Christchurch, New Zealand
    Psychopharmacology (Berl) 173:1-17. 2004
    ..It has been suggested that corticosteroid-serotonin interactions are central to the pathophysiology of depression. These interactions have been investigated in healthy and depressed humans, primarily using neuroendocrine techniques...
  9. ncbi request reprint Randomized controlled trials in psychiatry. Part 1: methodology and critical evaluation
    Richard Porter
    Department of Psychological Medicine, Christchurch School of Medicine, PO Box 4345, Christchurch 8001, New Zealand
    Aust N Z J Psychiatry 37:257-64. 2003
    ..To introduce clinicians to the methodology and critical appraisal of randomized controlled trials (RCTs) in psychiatry...
  10. ncbi request reprint Baseline prolactin and L-tryptophan availability predict response to antidepressant treatment in major depression
    Richard J Porter
    Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, P O Box 4345, Christchurch, New Zealand
    Psychopharmacology (Berl) 165:216-21. 2003
    ..It has been suggested that the PRF may predict response to different forms of treatment. Baseline cortisol, prolactin, and L-tryptophan ( L-TRP) availability may affect PRF and may also influence response to treatment...
  11. ncbi request reprint Randomized controlled trials in psychiatry. Part II: their relationship to clinical practice
    Roger T Mulder
    Department of Psychological Medicine, Christchurch School of Medicine, PO Box 4345, Christchurch, New Zealand
    Aust N Z J Psychiatry 37:265-9. 2003
    ..To discuss the extent to which the results of randomized controlled trials (RCTs) in psychiatry can be generalized to clinical practice...
  12. doi request reprint Effects of the addition of remifentanil to propofol anesthesia on seizure length and postictal suppression index in electroconvulsive therapy
    Richard Porter
    Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
    J ECT 24:203-7. 2008
    ..However, there are concerns that its anticonvulsant effect may interfere with the efficacy of ECT. We aimed to investigate the effects on seizure activity of the addition of the opiate remifentanil to propofol anesthesia for ECT...